U S PHYSICAL THERAPY INC /NV
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $781.0M | $671.3M | $604.8M | $553.1M | $495.0M | $423.0M | $482.0M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | $149.7M | $123.9M | $121.5M | $112.0M | $117.2M | $94.5M | $112.5M |
| Gross Margin | — | 19.2% | 18.5% | 20.1% | 20.3% | 23.7% | 22.3% | 23.3% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | — | $69.3M | $58.3M | $52.0M | $46.1M | $46.5M | $42.0M | $45.0M |
| Operating Income | — | $86.7M | $63.0M | $50.5M | $56.8M | $70.6M | $52.4M | $67.4M |
| Operating Margin | — | 11.1% | 9.4% | 8.4% | 10.3% | 14.3% | 12.4% | 14.0% |
| Interest Expense | — | — | — | — | — | — | — | $2.1M |
| Pretax Income | — | $77.8M | $60.2M | $49.4M | $55.6M | $73.2M | $65.5M | $70.9M |
| Income Tax Expense | — | $19.8M | $14.6M | $12.2M | $12.2M | $15.3M | $13.0M | $13.6M |
| Net Income | — | $39.6M | $31.4M | $28.2M | $32.2M | $40.8M | $35.2M | $40.0M |
| Net Margin | — | 5.1% | 4.7% | 4.7% | 5.8% | 8.2% | 8.3% | 8.3% |
| EPS (Basic) | — | $1.42 | $1.84 | $1.28 | $2.25 | $2.41 | $2.48 | $2.45 |
| EPS (Diluted) | — | $1.42 | $1.84 | $1.28 | $2.25 | $2.41 | $2.48 | $2.45 |
| Shares Outstanding (Basic) | 15.1M | 15.2M | 15.1M | 14.2M | 13.0M | 12.9M | 12.8M | 12.8M |
| Shares Outstanding (Diluted) | 15.1M | 15.2M | 15.1M | 14.2M | 13.0M | 12.9M | 12.8M | 12.8M |
| Dividends Per Share | — | $1.80 | $1.76 | $1.72 | $1.64 | $1.46 | $0.32 | $1.14 |